Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis

Abstract

Polymyositis and dermatomyositis are autoimmune idiopathic systemic inflammatory diseases, characterized by various degrees of muscle inflammation and typical cutaneous lesions—the latter found in dermatomyositis. The underlying pathogenesis is characterized by a high level of uncertainty, and recent studies suggest diseases may have different immunopathological mechanisms. In polymyositis, components of the cellular immune system are involved, whereas in dermatomyositis, the pathogenesis is mainly mediated by the humoral immune response. The interstitial lung disease occurs in one-third of polymyositis and dermatomyositis patients associated with worse outcomes, showing an estimated excess mortality rate of around 40%. Lung involvement may also appear, such as a complication of muscle weakness, mainly represented by aspiration pneumonia or respiratory insufficiency. The clinical picture is characterized, in most cases, by progressive dyspnea and non-productive cough. In some cases, hemoptysis and chest pain are found. Onset can be acute, sub-acute, or chronic. Pulmonary involvement could be assessed by High Resolution Computed Tomography (HRCT), which may identify early manifestations of diseases. Moreover, Computed Tomography (CT) appearances can be highly variable depending on the positivity of myositis-specific autoantibodies. The most common pathological patterns include fibrotic and cellular nonspecific interstitial pneumonia or organizing pneumonia; major findings observed on HRCT images are represented by consolidations, ground-glass opacities, and reticulations. Other findings include honeycombing, subpleural bands, and traction bronchiectasis. In patients having Anti-ARS Abs, HRCT features may develop with consolidations, ground glass opacities (GGOs), and reticular opacities in the peripheral portions; nonspecific interstitial pneumonia or nonspecific interstitial pneumonia mixed with organizing pneumonia have been reported as the most frequently encountered patterns. In patients with anti-MDA5 Abs, mixed or unclassifiable patterns are frequently observed at imaging. HRCT is a sensitive method that allows one not only to identify disease, but also to monitor the effectiveness of treatment and detect disease progression and/or complications; however, radiological findings are not specific. Therefore, aim of this pictorial essay is to describe clinical and radiological features of interstitial lung diseases associated with polymyositis and dermatomyositis, emphasizing the concept that gold standard for diagnosis and classification–should be based on a multidisciplinary approach.

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease

“…7 Previous studies have suggested that different ILD patterns in patients with IIM are associated with different prognoses. 8 However, large-scale clinical studies exploring the exact radiological and pathological features of anti-MDA5+DM-associated ILD (anti-MDA5+DM ILD) are still lacking, with only a few case reports and small-sample studies. [9][10][11] Accordingly, we aimed to clarify the clinical characteristics, radiological features and pathological features of anti-MDA5+DM ILD in a relatively large cohort and to identify the disease progression profile of different patterns of ILD.…”

Approach to Pulmonary Nodules in Connective Tissue Disease

“…PM and DM are autoimmune systemic inflammatory diseases characterized by proximal muscle weakness, systemic involvement and cutaneous manifestations, the latter a characteristic of DM. 72 The incidence of DM and PM is rare, ranging from 1.2 to 66 new cases per 1,000,000 person-years, and like other CTDs demonstrates a female predilection. 73 The presence of ILD is more strongly associated with having a positive anti-Jo 1 antibody with a prevalence of approximately 50 to 70%.…”

“…OP pattern is also described in PM/DM, characterized by patchy ground-glass opacities and in some cases demonstrating a characteristic nodular reverse halo appearance (central area of ground-glass opacification surrounded by peripheral rim of consolidation). 72 Anti-synthetase syndrome is a clinicoserologic syndrome associated with DM/ PM, defined by the association of an autoantibody against an aminoacyl-transfer RNA synthetase and various clinical manifestations. Debray et al described CT findings in 33 patients with anti-synthetase syndrome who had signs of ILD on CT and showed predominantly NSIP and NSIP-OP CT pattern.…”

COVID-19 Enfeksiyonunu Taklit Eden Polimiyozit Akciğer Tutulumu - Olgu Sunumu

“…Idiopathic inflammatory myopathy is a rare disorder that occurs in approximately 14-17 per 100,000 people. [9] Pulmonary involvement occurs in 9-60% of idiopathic inflammatory myopathy; it causes about 40% of disease-related mortality. [6,9] Diagnosis may be delayed in patients whose initial sign is diffuse interstitial lung disease and who are receiving corticosteroid therapy due to the suppression of musculoskeletal findings.…”

“…[9] Pulmonary involvement occurs in 9-60% of idiopathic inflammatory myopathy; it causes about 40% of disease-related mortality. [6,9] Diagnosis may be delayed in patients whose initial sign is diffuse interstitial lung disease and who are receiving corticosteroid therapy due to the suppression of musculoskeletal findings. [10] In our case, the initiation of steroid therapy with the primary diagnosis of COVID-19 infection caused a temporary improvement in symptoms.…”